IMAC Holdings, Inc. to Present at H.C. Wainwright BIOCONNECT Virtual Conference

Rhea-AI Summary

IMAC Holdings, Inc. (Nasdaq: IMAC) announced that CEO Jeffrey Ervin will present at the H.C. Wainwright BIOCONNECT Virtual Conference from January 10-13, 2022. The on-demand presentation will be available starting at 7:00 a.m. ET on January 10. IMAC Holdings specializes in health and wellness services, focusing on orthopedic, sports medicine, and life science therapies. The company operates over 15 outpatient medical clinics and is conducting a Phase I clinical trial for a stem cell therapy targeting Parkinson’s disease.

BRENTWOOD, Tenn., Jan. 04, 2022 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC) today announced that Jeffrey Ervin, Chief Executive Officer of IMAC, will present at the H.C. Wainwright BIOCONNECT Virtual Conference taking place January 10-13, 2022. The on-demand presentation will be available beginning at 7:00 a.m. ET on January 10, 2022.

About IMAC Holdings, Inc.

IMAC Holdings owns and manages health and wellness centers that deliver sports medicine, orthopedic, and life science therapies for movement restricting diseases. IMAC is comprised of three business segments: outpatient medical centers, The Back Space, and a clinical research division. With treatments to address the aging population, IMAC Holdings owns or manages more than 15 outpatient medical clinics and has partnered with several active and former professional athletes, including Ozzie Smith, David Price, Mike Ditka, and Tony Delk to promote a minimally invasive approach to sports medicine. IMAC’s The Back Space retail spine health and wellness treatment centers deliver chiropractic care within Walmart locations. IMAC’s research division is currently conducting a Phase I clinical trial evaluating a mesenchymal stem cell therapy candidate for bradykinesia due to Parkinson’s disease. For more information visit www.imacholdings.com.

# # #

IMAC Press Contact:
Laura Fristoe
ir@imacholdings.com

FAQ

When will IMAC Holdings present at the H.C. Wainwright BIOCONNECT Virtual Conference?

IMAC Holdings will present at the H.C. Wainwright BIOCONNECT Virtual Conference from January 10-13, 2022, with the on-demand presentation available starting at 7:00 a.m. ET on January 10.

What is the focus of IMAC Holdings' business?

IMAC Holdings focuses on health and wellness, providing sports medicine, orthopedic services, and life science therapies for movement-restricting diseases.

What clinical trial is IMAC Holdings currently conducting?

IMAC Holdings is conducting a Phase I clinical trial evaluating a mesenchymal stem cell therapy candidate for bradykinesia due to Parkinson’s disease.

How many outpatient medical clinics does IMAC Holdings operate?

IMAC Holdings operates more than 15 outpatient medical clinics.

Who are some notable partners of IMAC Holdings?

IMAC Holdings has partnered with several active and former professional athletes, including Ozzie Smith, David Price, Mike Ditka, and Tony Delk.